Lanean...
mTORC2 controls cancer cell survival by modulating gluconeogenesis
For rapid tumor growth, cancer cells often reprogram the cellular metabolic processes to obtain enhanced anabolic precursors and energy. The molecular changes of such metabolic rewiring are far from established. Here we explored the role of mTOR (mechanistic target of rapamycin), which serves as a k...
Gorde:
| Argitaratua izan da: | Cell Death Discov |
|---|---|
| Egile Nagusiak: | , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Nature Publishing Group
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4979518/ https://ncbi.nlm.nih.gov/pubmed/27551450 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cddiscovery.2015.16 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|